Table I.
RBC Iron | Storage Iron | Total Body Iron | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||
Group (n) | Enrollment, mg (%) | Final, mg (%) | ∆, mg (95%C.I.) | p | Enrollment, mg (%) | Final, mg (%) | ∆, mg (95%C.I.) | p | Enrollment, mg | Final, mg | ∆, mg (95%C.I.) | p |
No Pills (94) | 2172 (84%) | 2156 (85%) | −16 (−47, 17) | 0.34 | 418 (16%) | 379 (15%) | −38 (−100, 24) | 0.22 | 2589 | 2535 | −54 (−140, 31) | 0.21 |
Placebo (49) | 2064 (85%) | 2048 (86%) | −16 (−54, 22) | 0.41 | 366 (15%) | 325 (14%) | −41 (−122, 41) | 0.33 | 2429 | 2373 | −56 (−160, 47) | 0.28 |
19mg (57) | 2176 (87%) | 2236 (80%) | 60 (11, 109) | 0.02 | 335 (13%) | 541 (20%) | 206 (136, 275) | <0.0001 | 2511 | 2778 | 266 (116, 324) | <0.0001 |
38mg (73) | 2147 (85%) | 2187 (80%) | 40 (−1, 82) | 0.06 | 375 (15%) | 555 (20%) | 180 (107, 253) | <0.0001 | 2523 | 2743 | 220 (159, 373) | <0.0001 |
n = 273 is a subset of the larger cohort (n=555) and is comprised of donors with baseline and final visit venous samples available for testing